Agile Therapeutics (AGRX) Prices 15M Share Offering at $3/Sh

Agile Therapeutics, Inc. (NASDAQ: AGRX) today announced the pricing of its underwritten public offering of 15 million shares of its common stock at a public offering price of $3.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Agile Therapeutics, are expected to be approximately $45 million. In addition, Agile Therapeutics has granted the underwriters a 30-day option to purchase up to 2.25 million additional shares of common stock at the public offering price, less the underwriting discounts and commissions. All shares in the offering will be sold by Agile Therapeutics.

The joint book-running managers for the offering are RBC Capital Markets, William Blair and Oppenheimer & Co. In addition, H.C. Wainwright & Co., Maxim Group LLC, and Janney Montgomery Scott are acting as co-managers.

The offering is expected to close on or about February 25, 2020, subject to customary closing conditions.

You May Also Be Interested In

• CervoMed closes $10M stock offering at $4.00 per share
• Deep Fission raises $40M in public offering on Nasdaq
• RedHill Biopharma closes $6M private placement with warrant upside